The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Pre-mRNA splicing in disease and therapeutics
Open accessAbstract
In metazoans, alternative splicing of genes is essential for regulating gene expression and contributing to functional complexity. Computational predictions, comparative genomics, and transcriptome profiling of normal and diseased tissues indicate an unexpectedly high fraction of diseases are caused by mutations that alter splicing. Mutations in cis elements cause mis-splicing of genes that alter gene function and contribute to disease pathology. Mutations of core spliceosomal factors are associated with hematolymphoid neoplasias, retinitis pigmentosa, and microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1). Mutations in the trans regulatory factors that control alternative splicing are associated with autism spectrum disorder, amyotrophic lateral sclerosis (ALS), and various cancers. In addition to discussing the disorders caused by these mutations, this review summarizes therapeutic approaches that have emerged to correct splicing of individual genes or target the splicing machinery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665
Expansion of the eukaryotic proteome by alternative splicing
Nilsen, T. W., & Graveley, B. R. (2010) · Nature · doi:10.1038/nature08909 · Cited by 2,197
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology
Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H. (2011) · Nature · doi:10.1038/nature10110 · Cited by 1,874
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2779 · Cited by 1,335
Pre-mRNA splicing and human disease
Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,256
Self-citationSomatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
Characterizing the RNA targets and position-dependent splicing regulation by TDP-43
Tollervey, J. R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., König, J., Hortobágyi, T., Nishimura, A. L., Župunski, V., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2778 · Cited by 1,165
Cooper, T. A., Wan, L., & Dreyfuss, G. (2009) · Cell · doi:10.1016/j.cell.2009.02.011 · Cited by 1,159
Self-citationExon Recognition in Vertebrate Splicing
Berget, S. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2411 · Cited by 1,086
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,080
Splicing in disease: disruption of the splicing code and the decoding machinery
Wang, G.-S., & Cooper, T. A. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2164 · Cited by 1,050
Self-citationTDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
Lagier-Tourenne, C., Polymenidou, M., & Cleveland, D. W. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq137 · Cited by 1,021
Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 996
CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing
Shukla, S., Kavak, E., Gregory, M., Imashimizu, M., Shutinoski, B., Kashlev, M., Oberdoerffer, P., Sandberg, R., & Oberdoerffer, S. (2011) · Nature · doi:10.1038/nature10442 · Cited by 973
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60756-3 · Cited by 878
Disruption of Splicing Regulated by a CUG-Binding Protein in Myotonic Dystrophy
Philips, A. V., Timchenko, L. T., & Cooper, T. A. (1998) · Science · doi:10.1126/science.280.5364.737 · Cited by 818
Self-citationAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Functional consequences of developmentally regulated alternative splicing
Kalsotra, A., & Cooper, T. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3052 · Cited by 729
Self-citationSystemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Goemans, N. M., Tulinius, M., van den Akker, J. T., Burm, B. E., Ekhart, P. F., Heuvelmans, N., Holling, T., Janson, A. A., Platenburg, G. J., Sipkens, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011367 · Cited by 678
Mankodi, A., Takahashi, M. P., Jiang, H., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., & Thornton, C. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00563-4 · Cited by 672
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 664
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M., & Mizui, Y. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.16 · Cited by 657
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Kaida, D., Motoyoshi, H., Tashiro, E., Nojima, T., Hagiwara, M., Ishigami, K., Watanabe, H., Kitahara, T., Yoshida, T., Nakajima, H., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.18 · Cited by 650
Charlet-B., N., Savkur, R. S., Singh, G., Philips, A. V., Grice, E. A., & Cooper, T. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00572-5 · Cited by 619
Self-citationRecurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Graubert, T. A., Shen, D., Ding, L., Okeyo-Owuor, T., Lunn, C. L., Shao, J., Krysiak, K., Harris, C. C., Koboldt, D. C., Larson, D. E., et al. (2012) · Nature Genetics · doi:10.1038/ng.1031 · Cited by 580
Aartsma-Rus, A., Fokkema, I., Verschuuren, J., Ginjaar, I., van Deutekom, J., van Ommen, G.-J., & den Dunnen, J. T. (2009) · Human Mutation · doi:10.1002/humu.20918 · Cited by 575
Passini, M. A., Bu, J., Richards, A. M., Kinnecom, C., Sardi, S. P., Stanek, L. M., Hua, Y., Rigo, F., Matson, J., Hung, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001777 · Cited by 547
Jiang, H., Mankodi, A., Swanson, M. S., Moxley, R. T., & Thornton, C. A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh327 · Cited by 526
Splicing in action: assessing disease causing sequence changes
Baralle, D., & Baralle, M. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.029538 · Cited by 508
Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12
Holmes, S. E., O'Hearn, E. E., McInnis, M. G., Gorelick-Feldman, D. A., Kleiderlein, J. J., Callahan, C., Kwak, N. G., Ingersoll-Ashworth, R. G., Sherr, M., Sumner, A. J., et al. (1999) · Nature Genetics · doi:10.1038/70493 · Cited by 488
Splicing double: insights from the second spliceosome
Patel, A. A., & Steitz, J. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1259 · Cited by 478
RNA-MEDIATED NEUROMUSCULAR DISORDERS
Ranum, L. P. W., & Cooper, T. A. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113014 · Cited by 477
Self-citationKuyumcu-Martinez, N. M., Wang, G.-S., & Cooper, T. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.027 · Cited by 445
Self-citationSplicing-directed therapy in a new mouse model of human accelerated aging
Osorio, F. G., Navarro, C. L., Cadiñanos, J., López-Mejía, I. C., Quirós, P. M., Bartoli, C., Rivera, J., Tazi, J., Guzmán, G., Varela, I., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002847 · Cited by 432
Are splicing mutations the most frequent cause of hereditary disease?
López-Bigas, N., Audit, B., Ouzounis, C., Parra, G., & Guigó, R. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.047 · Cited by 412
A yeast functional screen predicts new candidate ALS disease genes
Couthouis, J., Hart, M. P., Shorter, J., DeJesus-Hernandez, M., Erion, R., Oristano, R., Liu, A. X., Ramos, D., Jethava, N., Hosangadi, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109434108 · Cited by 389
Cell Motility Is Controlled by SF2/ASF through Alternative Splicing of the Ron Protooncogene
Ghigna, C., Giordano, S., Shen, H., Benvenuto, F., Castiglioni, F., Comoglio, P. M., Green, M. R., Riva, S., & Biamonti, G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.026 · Cited by 389
Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
Wheeler, T. M., Sobczak, K., Lueck, J. D., Osborne, R. J., Lin, X., Dirksen, R. T., & Thornton, C. A. (2009) · Science · doi:10.1126/science.1173110 · Cited by 387
Krawczak, M., Thomas, N. S. T., Hundrieser, B., Mort, M., Wittig, M., Hampe, J., & Cooper, D. N. (2007) · Human Mutation · doi:10.1002/humu.20400 · Cited by 374
Caldenhoven, E., van Dijk, T. B., Solari, R., Armstrong, J., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., & de Groot, R. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13221 · Cited by 373
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Makishima, H., Visconte, V., Sakaguchi, H., Jankowska, A. M., Abu Kar, S., Jerez, A., Przychodzen, B., Bupathi, M., Guinta, K., Afable, M. G., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399774 · Cited by 370
Protein composition of the intranuclear inclusions of FXTAS
Iwahashi, C. K., Yasui, D. H., An, H.-J., Greco, C. M., Tassone, F., Nannen, K., Babineau, B., Lebrilla, C. B., Hagerman, R. J., & Hagerman, P. J. (2006) · Brain · doi:10.1093/brain/awh650 · Cited by 359
Understanding the role of TDP-43 and FUS/TLS in ALS and beyond
Da Cruz, S., & Cleveland, D. W. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.05.029 · Cited by 351
Fugier, C., Klein, A. F., Hammer, C., Vassilopoulos, S., Ivarsson, Y., Toussaint, A., Tosch, V., Vignaud, A., Ferry, A., Messaddeq, N., et al. (2011) · Nature Medicine · doi:10.1038/nm.2374 · Cited by 335
The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain
Gehman, L. T., Stoilov, P., Maguire, J., Damianov, A., Lin, C.-H., Shiue, L., Ares, M., Mody, I., & Black, D. L. (2011) · Nature Genetics · doi:10.1038/ng.841 · Cited by 331
An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
Moore, M. J., Wang, Q., Kennedy, C. J., & Silver, P. A. (2010) · Cell · doi:10.1016/j.cell.2010.07.019 · Cited by 316
Unbalanced alternative splicing and its significance in cancer
Venables, J. P. (2006) · BioEssays · doi:10.1002/bies.20390 · Cited by 299
RNA CUG Repeats Sequester CUGBP1 and Alter Protein Levels and Activity of CUGBP1
Timchenko, N. A., Cai, Z.-J., Welm, A. L., Reddy, S., Ashizawa, T., & Timchenko, L. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005960200 · Cited by 290
Lim, K. H., Ferraris, L., Filloux, M. E., Raphael, B. J., & Fairbrother, W. G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101135108 · Cited by 282
RNA Gain-of-Function in Spinocerebellar Ataxia Type 8
Daughters, R. S., Tuttle, D. L., Gao, W., Ikeda, Y., Moseley, M. L., Ebner, T. J., Swanson, M. S., & Ranum, L. P. W. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000600 · Cited by 278
Kimura, T., Nakamori, M., Lueck, J. D., Pouliquin, P., Aoike, F., Fujimura, H., Dirksen, R. T., Takahashi, M. P., Dulhunty, A. F., & Sakoda, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi223 · Cited by 275
Pentamidine reverses the splicing defects associated with myotonic dystrophy
Warf, M. B., Nakamori, M., Matthys, C. M., Thornton, C. A., & Berglund, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903234106 · Cited by 263
Corrionero, A., Miñana, B., & Valcárcel, J. (2011) · Genes & Development · doi:10.1101/gad.2014311 · Cited by 263
He, H., Liyanarachchi, S., Akagi, K., Nagy, R., Li, J., Dietrich, R. C., Li, W., Sebastian, N., Wen, B., Xin, B., et al. (2011) · Science · doi:10.1126/science.1200587 · Cited by 261
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
Mulders, S. A. M., van den Broek, W. J. A. A., Wheeler, T. M., Croes, H. J. E., van Kuik-Romeijn, P., de Kimpe, S. J., Furling, D., Platenburg, G. J., Gourdon, G., Thornton, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905780106 · Cited by 257
U2AF homology motifs: protein recognition in the RRM world
Kielkopf, C. L., Lücke, S., & Green, M. R. (2004) · Genes & Development · doi:10.1101/gad.1206204 · Cited by 253
Regulation of Alternative Splicing by Reversible Protein Phosphorylation
Stamm, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700034200 · Cited by 251
Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy
Ho, T. H., Bundman, D., Armstrong, D. L., & Cooper, T. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi162 · Cited by 242
Self-citationAssociation of TALS Developmental Disorder with Defect in Minor Splicing Component U4atac snRNA
Edery, P., Marcaillou, C., Sahbatou, M., Labalme, A., Chastang, J., Touraine, R., Tubacher, E., Senni, F., Bober, M. B., Nampoothiri, S., et al. (2011) · Science · doi:10.1126/science.1202205 · Cited by 228
A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding
Arambula, J. F., Ramisetty, S. R., Baranger, A. M., & Zimmerman, S. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901824106 · Cited by 221
NAKAJIMA, H., HORI, Y., TERANO, H., OKUHARA, M., MANDA, T., MATSUMOTO, S., & SHIMOMURA, K. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.1204 · Cited by 216
MBNL1 Is the Primary Determinant of Focus Formation and Aberrant Insulin Receptor Splicing in DM1
Dansithong, W., Paul, S., Comai, L., & Reddy, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410781200 · Cited by 212
Ngo, J. C. K., Chakrabarti, S., Ding, J.-H., Velazquez-Dones, A., Nolen, B., Aubol, B. E., Adams, J. A., Fu, X.-D., & Ghosh, G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.025 · Cited by 206
The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA Splicing
O'Brien, K., Matlin, A. J., Lowell, A. M., & Moore, M. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805556200 · Cited by 200
Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism
Martin, C. L., Duvall, J. A., Ilkin, Y., Simon, J. S., Arreaza, M. G., Wilkes, K., Alvarez‐Retuerto, A., Whichello, A., Powell, C. M., Rao, K., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30530 · Cited by 198
Pre-mRNA splicing is a determinant of histone H3K36 methylation
Kim, S., Kim, H., Fong, N., Erickson, B., & Bentley, D. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109475108 · Cited by 192
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy
Taniguchi-Ikeda, M., Kobayashi, K., Kanagawa, M., Yu, C.-C., Mori, K., Oda, T., Kuga, A., Kurahashi, H., Akman, H. O., DiMauro, S., et al. (2011) · Nature · doi:10.1038/nature10456 · Cited by 189
Green, R. E., Lewis, B. P., Hillman, R. T., Blanchette, M., Lareau, L. F., Garnett, A. T., Rio, D. C., & Brenner, S. E. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg1015 · Cited by 189
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
Krzyzosiak, W. J., Sobczak, K., Wojciechowska, M., Fiszer, A., Mykowska, A., & Kozlowski, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr729 · Cited by 187
MIZUI, Y., SAKAI, T., IWATA, M., UENAKA, T., OKAMOTO, K., SHIMIZU, H., YAMORI, T., YOSHIMATSU, K., & ASADA, M. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.188 · Cited by 185
Pushechnikov, A., Lee, M. M., Childs-Disney, J. L., Sobczak, K., French, J. M., Thornton, C. A., & Disney, M. D. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9020149 · Cited by 184
Barnby, G., Abbott, A., Sykes, N., Morris, A., Weeks, D. E., Mott, R., Lamb, J., Bailey, A. J., & Monaco, A. P. (2005) · The American Journal of Human Genetics · doi:10.1086/430454 · Cited by 179
Loss of exon identity is a common mechanism of human inherited disease
Sterne-Weiler, T., Howard, J., Mort, M., Cooper, D. N., & Sanford, J. R. (2011) · Genome Research · doi:10.1101/gr.118638.110 · Cited by 177
Antitumorigenic potential of STAT3 alternative splicing modulation
Zammarchi, F., de Stanchina, E., Bournazou, E., Supakorndej, T., Martires, K., Riedel, E., Corben, A. D., Bromberg, J. F., & Cartegni, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108482108 · Cited by 176
NAKAJIMA, H., SATO, B., FUJITA, T., TAKASE, S., TERANO, H., & OKUHARA, M. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.1196 · Cited by 174
Splicing of a rare class of introns by the U12-dependent spliceosome
Will, C. L., & Lührmann, R. (2005) · Biological Chemistry · doi:10.1515/bc.2005.084 · Cited by 166
Genetic therapies for RNA mis-splicing diseases
Hammond, S. M., & Wood, M. J. A. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.02.004 · Cited by 165
Insulin Receptor Splicing Alteration in Myotonic Dystrophy Type 2
Savkur, R. S., Philips, A. V., Cooper, T. A., Dalton, J. C., Moseley, M. L., Ranum, L. P. W., & Day, J. W. (2004) · The American Journal of Human Genetics · doi:10.1086/421528 · Cited by 162
Self-citationRNA-binding proteins with prion-like domains in ALS and FTLD-U
Gitler, A. D., & Shorter, J. (2011) · Prion · doi:10.4161/pri.5.3.17230 · Cited by 161
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
LeFave, C. V., Squatrito, M., Vorlová, S., Rocco, G., Brennan, C., Holland, E. C., Pan, Y., & Cartegni, L. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.259 · Cited by 160
RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1
Lee, J. E., Bennett, C. F., & Cooper, T. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117019109 · Cited by 158
Self-citationHierarchical, clustered protein interactions with U4/U6 snRNA: a biochemical role for U4/U6 proteins
Nottrott, S., Urlaub, H., & Lührmann, R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf544 · Cited by 157
Identification of SAP155 as the Target of GEX1A (Herboxidiene), an Antitumor Natural Product
Hasegawa, M., Miura, T., Kuzuya, K., Inoue, A., Ki, S. W., Horinouchi, S., Yoshida, T., Kunoh, T., Koseki, K., Mino, K., et al. (2010) · ACS Chemical Biology · doi:10.1021/cb100248e · Cited by 153
Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells
Buj‐Bello, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.19.2297 · Cited by 144
Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies
Dhir, A., & Buratti, E. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07520.x · Cited by 135
Luco, R. F., & Misteli, T. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.03.004 · Cited by 134
SAKAI, T., Sameshima, T., Matsufuji, M., Kawamura, N., Dobashi, K., & Mizui, Y. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.173 · Cited by 131
Yoon, S.-O., Shin, S., Lee, H.-J., Chun, H., & Chung, A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0321 · Cited by 126
Transposable elements in disease-associated cryptic exons
Vořechovský, I. (2009) · Human Genetics · doi:10.1007/s00439-009-0752-4 · Cited by 119
A conserved splicing mechanism of the LMNA gene controls premature aging
López‐Mejía, I. C., Vautrot, V., de Toledo, M., Behm‐Ansmant, I., Bourgeois, C. F., Navarro, C. L., Osorio, F. G., Freije, J. M. P., Stévenin, J., Sandre‐Giovannoli, A. D., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr385 · Cited by 109
Chandler, D. S., Singh, R. K., Caldwell, L. C., Bitler, J. L., & Lozano, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4271 · Cited by 108
Self-citationGarcía-López, A., Llamusí, B., Orzáez, M., Pérez‐Payá, E., & Artero, R. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018213108 · Cited by 103
Shen, H., Zheng, X., Luecke, S., & Green, M. R. (2010) · Genes & Development · doi:10.1101/gad.1974810 · Cited by 101
Ek, C. J., Habgood, M. D., Dzięgielewska, K. M., & Saunders, N. R. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10661 · Cited by 100
Albert, B. J., McPherson, P. A., O'Brien, K., Czaicki, N. L., DeStefino, V. J., Osman, S., Li, M., Day, B. W., Grabowski, P. J., Moore, M. J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0051 · Cited by 99
Developments in RNA Splicing and Disease
Poulos, M. G., Batra, R., Charizanis, K., & Swanson, M. S. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000778 · Cited by 98
RNA-targeted splice-correction therapy for neuromuscular disease
Wood, M. J. A., Gait, M. J., & Yin, H. (2010) · Brain · doi:10.1093/brain/awq002 · Cited by 93
Hirabayashi, S., Flotho, C., Moetter, J., Heuser, M., Hasle, H., Gruhn, B., Klingebiel, T. E., Thol, F. R., Schlegelberger, B., Baumann, I., et al. (2012) · Blood · doi:10.1182/blood-2011-12-395087 · Cited by 71
SnapShot: The Splicing Regulatory Machinery
Gabut, M., Chaudhry, S., & Blencowe, B. J. (2008) · Cell · doi:10.1016/j.cell.2008.03.010 · Cited by 66
Chang, J., Yang, D.-M., Chang, W.-H., Chow, L., Chan, W.-L., Lin, H.-H., Huang, H.-D., Chang, Y., Hung, C.-H., & Yang, W.-K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018643 · Cited by 63
DBASS3 and DBASS5: databases of aberrant 3'- and 5'-splice sites
Buratti, E., Chivers, M., Hwang, G., & Vořechovský, I. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq887 · Cited by 62
Ezponda, T., Pajares, M. J., Agorreta, J., Echeveste, J. I., López-Picazo, J. M., Torre, W., Pı́o, R., & Montuenga, L. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0076 · Cited by 55
Therapeutics development in myotonic dystrophy type 1
Foff, E. P., & Mahadevan, M. S. (2011) · Muscle & Nerve · doi:10.1002/mus.22090 · Cited by 52
Ahn, E.-Y., Yan, M., Malakhova, O. A., Lo, M., Boyapati, A., Ommen, H. B., Hines, R., Hokland, P., & Zhang, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802696105 · Cited by 47
Present and future of antisense therapy for splicing modulation in inherited metabolic disease
Pérez, B., Rodríguez‐Pascau, L., Vilageliu, L., Grinberg, D., Ugarte, M., & Desviat, L. R. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9135-1 · Cited by 46
Alternative splicing and breast cancer
Dutertre, M., Vagner, S., & Auboeuf, D. (2010) · RNA Biology · doi:10.4161/rna.7.4.12152 · Cited by 44
Using non-coding small RNAs to develop therapies for Huntington's disease
Zhang, Y., & Friedlander, R. M. (2011) · Gene Therapy · doi:10.1038/gt.2011.170 · Cited by 39
Alternative Splicing: Therapeutic Target and Tool
García-Blanco, M. A. (2006) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-34449-0_3 · Cited by 30
Dominant negative STAT3 suppresses the growth and invasion capability of human lung cancer cells
Zhang (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000178 · Cited by 27
Cited by
Cui, P., Zhang, S., Ding, F., Ali, S., & Xiong, L. (2014) · Genome Biology · doi:10.1186/gb-2014-15-1-r1 · Cited by 2,294
Alternative splicing as a regulator of development and tissue identity
Baralle, F. E., & Giudice, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.27 · Cited by 1,333
Scotti, M. M., & Swanson, M. S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.3 · Cited by 1,163
A day in the life of the spliceosome
Matera, A. G., & Wang, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3742 · Cited by 1,074
Genetic diagnosis of Mendelian disorders via RNA sequencing
Kremer, L. S., Bader, D. M., Mertes, C., Kopajtich, R., Pichler, G., Iuso, A., Haack, T. B., Graf, E., Schwarzmayr, T., Terrile, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15824 · Cited by 590
Metadata
- Authors
- Singh, R. K., & Cooper, T. A.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 18
- Issue
- 8
- Pages
- 472-482
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1987374058
- Cited by
- 459
- References
- 120
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.